Navigation Links
Quality of medicines and food ingredients the focus at USP 2009 Annual Scientific Meeting
Date:9/9/2009

Rockville, Md., September 9, 2009 Important issues surrounding the quality of food and drugsincluding global supply chain management, the challenges of creating follow-on biologics (in Canada, subsequent entry biologics) and nanotechnology for drug deliverywill be the focus of the U.S. Pharmacopeial (USP) Convention's 2009 Annual Scientific Meeting (ASM). The ASM will be held in Toronto, Canada, from September 22 to 25.

"We have a strong international roster of top scientific and regulatory experts in pharmaceuticals, food, biotechnology and measurement," said Roger L. Williams, M.D., chief executive officer of USP. "Navigating the complexities of global supply chain management, quality of food ingredients and understanding how measurement science can be utilized are key to ensuring the quality and safety of the world's medicines and food ingredients. I'm looking forward to a rigorous and forward-moving discussion."

Given urgent challenges in protecting the quality of drugs and foodsincluding melamine in food products, adulterated heparin, and diethylene glycol in cough syrups and toothpastethis year's ASM is especially timely and critical. This scientific dialogue will engage more than 200 experts from all over the world who will focus on such topics as the special challenges posed by biologic products, bioterrorism and advanced techniques for detecting protein, among many others.

A special pre-ASM Tuesday session on Adulteration and Contamination: Technologies of the Future will address the role of emerging technologies in protecting the global supply of food and drugs. Speakers include Steve Choquette from the National Institute of Standards and Technology on spectral identification, which allow more precise identification of substandard materials; David Hale from the National Institutes of Health/National Library of Medicine on advanced imaging/high resolution photography; and Anthony Zook from Merck & Company on advanced detec
'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Page: 1 2

Related biology news :

1. Water quality improves after lawn fertilizer ban, study shows
2. Improved air quality during Beijing Olympics could inform pollution-curbing policies
3. Dietary supplements manufacturers gain new tool to help ensure quality products
4. Quality and purity of popular stevia sweetener strengthened by new reference standards
5. Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution
6. Enhanced quality of LIFE through Nordic food
7. Houseplants increase quality of life for retirement community residents
8. Healthy food availability could depend on where you live -- so does the quality of your diet
9. New research shows high-quality protein in eggs contributes to power, strength and energy
10. New standard for popular stevia-based sweetener to assure products quality
11. Biological sand filters, a practical approach to combat poverty and inequality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)...   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ... and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/11/2014)... --Research and Markets , ... ) has announced the addition of the ... to their offering. One major ... technology. With continuous advances in technology, it is ... standard that meets the needs and expectations of ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... HOUSTON (Nov. 8, 2012) Four young scientists ... Research Institute (NSBRI). Through this two-year program, they conduct ... during long-duration spaceflights. In addition to receiving mentorship from ... are members of one of NSBRI,s seven research teams. ...
... in removing the extra copy of chromosome 21 in ... In Down syndrome, the body,s cells contain three ... A triplicate of any chromosome is a serious ... one-quarter of pregnancy loss from spontaneous miscarriages, according to ...
... 2012  Genomic Health, Inc. (Nasdaq: GHDX ) today ... Officer, Chairman and President will present at the following conferences ... on Thursday, November 15, 2012 at 2:00 p.m. Mountain Time ... Jaffray Healthcare Conference on Tuesday, November 27 at 2:30 p.m. ...
Cached Biology News:Space research institute awards postdoctoral fellowships to 4 scientists 2Extra chromosome 21 removed from Down syndrome cell line 2Extra chromosome 21 removed from Down syndrome cell line 3Genomic Health to Present at Two Upcoming Investor Conferences 2Genomic Health to Present at Two Upcoming Investor Conferences 3
(Date:12/19/2014)... 2014 Today, TiFiber, Inc. ... production facility and future company headquarters in Fort ... new materials that safely and effectively control dangerous ... of its historic, strong support for manufacturing, but ... leading edge, technology-based companies such as TiFiber. ...
(Date:12/19/2014)... Biddeford, ME (PRWEB) December 18, 2014 ... founding director of the Center for Excellence in the ... of New England, has been selected as a member ... He is the first neuroscientist from Maine to receive ... a nonprofit organization supported entirely by the Dana Foundation. ...
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... (PRWEB) December 19, 2014 The ... to the rising ageing population and technological innovations ... and nutraceutical industries are catalysing the growth of ... @ http://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html , Scope of Report ... as well as new entrants/smaller firms to gauge ...
Breaking Biology Technology:Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 2UNE's Ed Bilsky Named Member of Dana Alliance for Brain Initiatives 3iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4
... Stock Exchange Symbol: MS, EDMONTON, April 15 /PRNewswire-FirstCall/ ... the treatment of multiple sclerosis (MS), today,announced that Mr. ... EQUITIES Magazine,s 57th Anniversary Spring Conference., WHEN: ... AM (Eastern Time), WHERE: The ...
... SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) presented abstract #4844 ... Cancer Research (AACR) in San Diego. The poster,entitled "SGX523, ... tyrosine kinase (MET), inhibits growth of human glioblastoma,tumors in ... session,entitled Small Molecule Kinase Inhibitors 1 in Exhibit Hall ...
... Therapeutics,Inc. (Nasdaq: CVTX ) announced today that ... to $185 million in exchange for rights to ... sales of Lexiscan(TM),(regadenoson) injection. CV Therapeutics received $175 ... a potential future milestone payment,of $10 million., ...
Cached Biology Technology:BioMS Medical to present at EQUITIES Conference 2SGX Presents Preclinical MET Data at AACR 2SGX Presents Preclinical MET Data at AACR 3CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection 2CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection 3
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Biology Products: